Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELIEF: Olmesartan in PAD with Hypertension
NCT02373462Phase 4Terminated
- Sponsor
- Yonsei University
- Start
- Aug 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olmesartan in intermittent claudication (IC), peripheral artery disease (PAD), sponsored by Yonsei University. Started Aug 2015; status: terminated.
02
Drugs
olmesartan
03
Conditions
intermittent claudication (IC)peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT02373462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02373462.